Wegovy pill
Daily oral semaglutide. Morning fasting and water rules apply.
Compare details →Medication-by-medication review · updated October 26, 2026
Rybelsus: oral semaglutide for type 2 diabetes
Rybelsus is an FDA-approved daily semaglutide tablet for type 2 diabetes. It is not a weight-loss-approved substitute for Wegovy tablets.
Medication-specific access — not a generic redirect
Where to review this exact medication: View the medication-specific Sesame page →
Untracked editorial link. No verified affiliate attribution for this drug-specific URL. A prescription is never guaranteed.
A page about this medication is not evidence of affiliate deep-link approval or of guaranteed availability. A licensed prescriber determines whether a prescription is appropriate.
What you are comparing
Start with the exact medicine, then confirm prescription eligibility, total costs and pharmacy fulfillment. The links below are to real medication pages, not generic injectable offers.
Rybelsus contains semaglutide, but its FDA indication is treatment of adults with type 2 diabetes and related labeled cardiovascular-risk reduction in certain patients. The fact that it shares an ingredient with Wegovy does not make it a branded weight-management medication. Rybelsus is not approved specifically for weight loss.
- FDA-approved diabetes medication, not approved specifically for obesity treatment.
- Administration typically requires an empty stomach, up to four ounces of plain water, then a 30-minute wait before food, other drinks or oral medicines.
- Rybelsus, Wegovy tablets and newer Ozempic tablets have different formulations or indications; never translate doses milligram-for-milligram.
- Prices and formulary coverage vary widely. Do not quote an older marketing “starting from” number as today’s total treatment cost.
Who is this comparison for?
Someone seeking diabetes treatment should discuss glycemic goals and insurance formulary with a clinician. Someone seeking an FDA-approved weight-management pill should start by comparing oral Wegovy and Foundayo rather than treating Rybelsus as a generic equivalent.
Price and practical checks
No universal self-pay price stated; confirm the exact formulation, insurer formulary, pharmacy and visits.
Before paying, confirm pharmacy cost, consultation and subscription fees, shipping, lab charges, insurance restrictions, renewal cost, cancellation policy, and whether your state is supported. Promotional manufacturer pricing is not a guaranteed final invoice.
Read current FDA label or safety guidance →Related medication guides
Foundayo
Daily orforglipron. May be taken with or without food.
Compare details →Rybelsus
Daily oral semaglutide. Not approved specifically for weight loss.
Compare details →Compounded oral GLP-1s
Compounded drops, dissolving tablets and other forms have not been FDA-reviewed.
Compare details →Editorial and commercial disclosure
This site provides independently written comparison information, not medical care. Some older articles contain historical prices and provider references. Medication-specific Sesame, manufacturer, and FDA links on this page are untracked editorial links; a commission relationship for those precise landing pages has not been established. Any separately marked sponsored program is not guaranteed to prescribe this medication.
Sources are linked on the page; verify latest labeling, current price, availability, insurance conditions and eligibility with the manufacturer, licensed clinician and dispensing pharmacy. Do not start, switch or combine prescription GLP-1 medications without medical advice. This page does not provide individualized prescribing instructions.